Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Coote, Michael"'
Autor:
FA Medeiros, TR Walters, M Kolko, Coote, Michael, M Bejanian, ML Goodkin, Q Guo, J Zhang, MR Robinson, RN Weinreb, A Agar, R Bathijia, L Liu, T Roberts, C Faschinger, C Vass, N Collignon, AC Alves Pereira, R Belfort De Mattos, FJ Dantas, MJ Lopes Da Silva, F Kanadani, L Magacho Dos Santos Silva, T Prata, D Bach-Holm, J Lai, C Tham, G Bátor, L Szalczer, B Varsányi, E Blumenthal, O Geyer, S Lavartovsky, T Pedut-Kloizman, N Shoham-Hazon, S Lujan, B Abela, RE Ang, EU Leuenberger, H Uy, MI Yap-Veloso, P Fryczkowski, P Jurowski, B Kalużny, J Kalużny, M Misiuk-Hojlo, K Raczynska, W Tomczyk-Dorozynska, J Wasyluk, S Zalewski, T Zarnowski, JG Feijoó, R Giménez-Gómez, EM Griño, AA López, MG Miralles, JM Moreno, V Polo, EC Taulet, BP Zúñiga, YY Chen, YC Lee, L Alpern, MS Berlin, J Brubaker, D Caldwell, A Camp, LB Cantor, R Caronia, CJ Crane, D Day, E Duzman, J Elfervig, S El-Harazi, R Evans, AC Fisher, WJ Flynn, CS Foster, R Frenkel, R Goyal, R Gross, PJ Hartman, WL Haynes, G Jerkins, J Kim, M Kim, B Kwapiszeski, B Lambright, C Larsen, J Lehmann, JH Levenson, D Logan, B McMillan, JR Martel, H Mayer, F Medeiros, S Moroi, A Moyes, J Myers, J Nairn
© 2020 American Academy of Ophthalmology Purpose: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of 10- and 15-μg bimatoprost implant in subjects with open-angle glaucoma (OAG) and ocular hypertension (OHT) after initial an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c062a84d4d7b4dd145a591e52e4876fd
Autor:
ER Craven, T Walters, WC Christie, DG Day, RA Lewis, ML Goodkin, M Chen, V Wangsadipura, MR Robinson, M Bejanian, T Aung, AD Beck, JD Branch, Coote, Michael, CJ Crane, A Crichton, S Day, FJ Durcan, RM Evans, WJ Flynn, S Gagné, DF Goldberg, JV Greiner, P Jeppsen, D Jinapriya, CS Johnson, S Kurtz, SL Mansberger, JR Martel, SA Perera, MH Rotberg, RM Saltzmann, HI Schenker, ME Tepedino, MIR Yap-Veloso, HS Uy, TR Walters
© 2019, The Author(s). Objective: The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus top
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ea58d8304cb967ef750de94acf1d7a7